MAXHEALTH - It is time for 1000?
As always, the chart is easy to read and understand.
Here are a couple of highlights for this case study:
Disclaimer: This analysis is for educational purposes only and should not be considered as financial advice or a recommendation to buy, sell, or hold any securities. The information provided is based on historical data and market observations and does not guarantee future performance. Please conduct your own research or consult with a financial advisor before making any investment decisions. Trading in the stock market involves risk, and past performance is not indicative of future results.
Here are a couple of highlights for this case study:
- Observed a strong breakout with a long candle, currently in a retest phase.
- Recent price action shows a clear buyer bias.
- Key support levels are holding at 892 and 864.
- The 21-weekly EMA provides additional support.
- Volume spiked significantly in the last two weeks.
- The healthcare sector is trending upward.
- The first major resistance level to watch is around the 1000 mark.
Disclaimer: This analysis is for educational purposes only and should not be considered as financial advice or a recommendation to buy, sell, or hold any securities. The information provided is based on historical data and market observations and does not guarantee future performance. Please conduct your own research or consult with a financial advisor before making any investment decisions. Trading in the stock market involves risk, and past performance is not indicative of future results.
Note
Initial Momentum sets in..
Note
If it helped, Do give us a boost ..
Note
🎯 You can now access our personal charts for all Nifty 500 companies📈
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.